Regulations.gov document
Exocrine Pancreatic Insufficiency Drug Products for Over-the-Counter Human Use; Proposed…
Notice · FDA-1979-N-0029 · posted Jul 17, 1991
Key facts
| Document ID | FDA-1979-N-0029-0009 |
|---|---|
| Title | Exocrine Pancreatic Insufficiency Drug Products for Over-the-Counter Human Use; Proposed Rulemaking |
| Document type | Notice |
| Subtype | Proposed Guidelines |
| Agency | FDA |
| Docket | FDA-1979-N-0029 |
| Posted | Jul 17, 1991 |
| Federal Register citation | 56 FR 32282 |
| FR document number | 91-16596 |
| CFR | 21 CFR Parts 310 and 357 |
| Comment period opens | Jul 17, 1991 |
| Comments due | Nov 13, 1991 |
| Effective date | May 31, 1991 |
At a glance
- 10–99 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: